查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1824451

2025年放射治疗全球市场报告

Radiotheranostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年放射治疗市场将快速成长，到2029年将达到168.7亿美元，年复合成长率(CAGR)为13.8%。预测期内的增长归因于标靶癌症治疗的进步、肿瘤学研究的拓展、慢性病的增加以及治疗诊断应用的不断增长。预测期内的主要趋势包括治疗诊断放射性药物的发展、肿瘤学以外的应用扩展、个人化放射性药物、放射治疗中的奈米技术、监管变革以及标准化。

未来五年13.8%的成长预测比我们先前的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会扰乱美国供应链，增加从荷兰和韩国进口的氟脱氧葡萄糖-正子断层扫描放射性示踪剂和热凝探针的成本，从而可能限制标靶治疗，并增加诊断成像的负担。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，其影响可能会更加广泛。

预计癌症发生率的上升将在未来推动放射治疗市场的成长。癌症的特征是体内某些细胞不受控制地发展并转移到其他部位。放射治疗药物广泛应用于肿瘤学，透过配对诊断和治疗放射性核种探针，提供了个人化医疗的概念。这些探针能够根据患者的具体情况选择性地、有针对性地检测和治疗特定细胞（通常是癌细胞），从而提高治疗效果并改善临床结果。例如，2024 年 1 月，专注于癌症宣传的美国非营利组织美国癌症协会报告称，美国癌症患者人数从 2023 年的 1,958,310 人增加到 2,011,140 人，增长了 2.19%。因此，癌症发生率的上升正在推动放射治疗市场的发展。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球放射热学：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球放射热疗市场：增长率分析
  • 全球放射治疗市场表现：规模与成长，2019-2024
  • 全球放射治疗市场预测：2024-2029 年及 2034 年规模与成长
  • 全球放射治疗学：总目标市场（TAM）

第六章 市场细分

  • 全球放射热疗市场：依放射性同位素、实际与预测，2019-2024 年、2024-2029 年、2034 年
  • Technetium-99
  • 镓-68
  • 碘-131
  • 碘-123
  • 氟脱氧葡萄糖-18F
  • 钇90
  • 镏（Lu）177
  • 铜（Cu）67
  • 铜（Cu）64
  • 其他放射性同位素
  • 全球放射热疗市场：依方法、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 标靶治疗
  • 针对性的诊断
  • 全球放射热成像市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 肿瘤学
  • 非肿瘤学
  • 全球放射热疗市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 製药和生物技术公司
  • 其他最终用户
  • 全球放射性热疗市场：Technetium-99细分市场（依放射性同位素划分），2019-2024年、2024-2029、2034年
  • Technetium-99m
  • Technetium-99Technetium
  • 全球放射热成像市场：镓-68 细分（依放射性同位素）、实际及预测（2019-2024 年、2024-2029 年、2034 年）
  • 镓-68碘酸盐
  • 镓-68 PSMA
  • 全球放射热疗市场：碘-131细分市场（按放射性同位素），2019-2024年、2024-2029年、2034年
  • 碘-131在甲状腺癌治疗的应用
  • 碘-131治疗甲状腺亢进
  • 全球放射热疗市场：碘-123 细分市场（依放射性同位素划分）、实际及预测（2019-2024 年、2024-2029 年、2034 年）
  • 碘-123用于甲状腺扫描
  • 碘-123用于心臟影像影像
  • 全球放射热疗市场：氟脱氧葡萄糖-18F (FDG) 细分市场（按放射性同位素划分），实际及预测，2019-2024 年、2024-2029 年、2034 年
  • FDG用于肿瘤成像
  • FDG用于脑部影像
  • 全球放射性热成像市场：钇-90 细分市场（依放射性同位素）、实际及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 钇-90微球用于治疗肝癌
  • 钇-90用于放射免疫治疗
  • 全球放射性热疗市场：镏(Lu) 177 细分市场（依放射性同位素划分），2019-2024 年、2024-2029 年、2034 年实际及预测
  • 镏 - 177 PSMA 用于治疗前列腺癌
  • 镏-177 Dotatate 用于神经内分泌肿瘤
  • 全球放射性热疗市场：按铜 (Cu)-67（按放射性同位素）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 铜-67用于标靶放射线治疗
  • 铜-67 临床试验
  • 全球放射热成像市场：按铜（Cu）-64（按放射性同位素）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 用于PET成像的铜-64
  • 铜64用于放射治疗
  • 全球放射性热疗市场：细分：其他放射性同位素（按放射性同位素），实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 镭 223，钐 153
  • 治疗诊断学中的其他新兴放射性同位素

第七章 区域和国家分析

  • 全球放射热疗市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球放射热疗市场：按国家、实际结果和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 放射治疗市场：竞争格局
  • 放射治疗市场：公司简介
    • Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Siemens Healthineers
  • Orano Med
  • Curium SAS
  • IBA Molecular
  • The Eckert & Ziegler Group
  • Advanced Accelerator Applications（AAA）
  • Telix Pharmaceuticals Limited.
  • Abdera Therapeutics
  • Blue Earth Diagnostics
  • Sirtex Medical Limited
  • Y-mAbs Therapeutics Inc.
  • ITM Radiopharma
  • NorthStar Medical Radioisotopes LLC
  • Trasis SA
  • Molecular Targeting Technologies Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年放射治疗市场：提供新机会的国家
  • 2029 年放射治疗市场：细分领域带来新机会
  • 2029年放射热成像市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r25249u

Radiotheranostics refers to a medical approach that combines diagnoses and treatments using imaging methods with radioactive substances to precisely identify specific targets within the body. This method is employed for delivering targeted radiation therapy to defined locations, enabling precise and tailored cancer treatment while minimizing damage to healthy tissues. This approach enhances treatment outcomes and improves patient care.

The primary radiotheranostics radioisotopes include technetium-99, gallium-68, iodine-131, iodine-123, fludeoxyglucose-18F, yttrium-90, lutetium (Lu) 177, copper (Cu) 67, copper (Cu) 64, and others. Technetium (Tc) is a silver-gray radioactive metal that occurs naturally at extremely low levels in the earth's crust but is predominantly man-made. It is used for skeletal and heart muscle scans and imaging of various organs such as the brain, thyroid, lungs, liver, spleen, kidneys, gall bladder, bone marrow, salivary and lacrimal glands, as well as in some specialized medical research. The different approaches include targeted therapeutic and targeted diagnostic applications in both oncology and non-oncology. The end users of this technology include hospitals and clinics, pharmaceutical and biotechnology companies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The radio theranostics market research report is one of a series of new reports from The Business Research Company that provides radio theranostics market statistics, including radio theranostics industry global market size, regional shares, competitors with a radio theranostics market share, detailed radio theranostics market segments, market trends, and opportunities, and any further data you may need to thrive in the radio theranostics industry. This radio theranostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The radiotheranostics market size has grown rapidly in recent years. It will grow from $8.79 billion in 2024 to $10.05 billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to advancements in nuclear medicine, a rise in cancer cases, personalized medicine development, advances in radiopharmaceuticals, regulatory approvals and standards.

The radiotheranostics market size is expected to see rapid growth in the next few years. It will grow to $16.87 billion in 2029 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to advancements in targeted cancer therapies, expansion in oncology research, rise in chronic diseases, and growth in theranostic applications. Major trends in the forecast period include theranostic radiopharmaceutical development, expanding applications beyond oncology, personalized radiopharmaceuticals, nanotechnology in radiotheranostics, regulatory shifts and standardization.

The forecast of 13.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. supply chains by increasing costs for luorodeoxyglucose-Positron Emission Tomography -Positron Emission Tomography radiotracers and theranostic probes imported from the Netherlands and South Korea, potentially limiting targeted oncology therapies and raising diagnostic imaging burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of cancer is anticipated to drive the growth of the radiotheranostics market in the future. Cancer is characterized by the uncontrolled development of certain cells in the body that spread to other areas. Radiotheranostics medications are widely used in oncology to provide the concept of personalized medicine through paired diagnostic and therapeutic radionuclide probes. These probes enable selective and targeted detection and treatment of specific (typically cancerous) cells, tailored to the patient's specific condition to enhance treatment efficacy and improve clinical outcomes. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization focused on cancer advocacy, reported an increase in cancer cases to 2,001,140, up from 1,958,310 in 2023, marking a growth of 2.19%. Thus, the increasing prevalence of cancer is propelling the radiotheranostics market.

The increasing adoption of personalized medicine is poised to contribute to the growth of the radiotheranostics market. Personalized medicine, an innovative healthcare approach tailoring medical treatments to individual patient characteristics, is facilitated by radiotheranostics. This approach, utilizing specific radiopharmaceuticals, enables the identification of individualized molecular targets, allowing for precise diagnosis and tailored therapeutic interventions based on the patient's unique characteristics. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines, according to the Personalized Medicine Coalition. The increasing adoption of personalized medicine is a key driver for the growth of the radiotheranostics market.

An emerging trend in the radiotheranostics market is the focus on product innovations. Major companies are directing their efforts towards creating innovative products to solidify their market positions. For instance, Advanced Cyclotron Systems Inc., a Canada-based company specializing in cyclotrons for medical isotope production, introduced TR-ALPHA in May 2023. This innovation is designed for the production of alpha-emitting radioisotopes used in cancer treatment. TR-ALPHA addresses market demands for a low-cost cyclotron capable of producing substantial amounts of Astatine-211, a promising alpha-emitting radioisotope. This product is smaller, more cost-effective, and easier to operate compared to previous cyclotron models, making it an ideal solution for efficiently producing therapeutic alpha-emitting radioisotopes.

Major companies in the radiotheranostics market are forming strategic partnerships to develop new products and strengthen their market positions. Collaborations and partnerships in this market facilitate the pooling of resources, expertise, and research efforts, accelerating the development, commercialization, and widespread adoption of advanced diagnostic and therapeutic solutions. In April 2022, Ion Beam Applications partnered with SCK CEN to advance the production of the radioisotope Actinium-225, a crucial element in cancer treatment. This collaboration aims to establish a state-of-the-art production facility in Mol, Belgium, combining expertise in particle accelerators and the provision of rare raw materials. Such collaborations are crucial for making radiotheranostic solutions commercially viable for treating various cancers with enhanced precision.

In June 2023, Ariceum Therapeutics GmbH, a Germany-based radiopharmaceutical company, acquired Theragnostics Ltd. for $41.5 million. This strategic acquisition is intended to broaden Ariceum's portfolio of therapeutic and diagnostic assets in late preclinical and early clinical development and expand its operations in the US. Theragnostics Ltd., a US-based radiopharmaceutical company, specializes in offering radio-theranostic solutions.

Major companies operating in the radiotheranostics market include Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc, Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., Navidea Biopharmaceuticals Inc.

North America was the largest region in the radiotheranostics market in 2024. The regions covered in the radiotheranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the radiotheranostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiotheranostics market consists of sales of iodine-125, radium-223 (223Ra), astatin-211 (211At), actinium-225 (225Ac), lead-212 (212Pb), bismuth-212 (212Bi), thorium-227, strontium-89 (89Sr), rhenium-188 (188Re), and samarium-153 (153Sm). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiotheranostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiotheranostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiotheranostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The radiotheranostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Radioisotope: Technetium-99; Gallium-68; Iodine-131; Iodine-123; Fludeoxyglucose-18F; Yttrium-90; Lutetium (Lu) 177; Copper (Cu) 67; Copper (Cu) 64; Other Radioisotopes
  • 2) By Approach: Targeted Therapeutic; Targeted Diagnostic
  • 3) By Application: Oncology; Non-Oncology
  • 4) By End-Users: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users
  • Subsegments:
  • 1) By Technetium-99: Technetium-99m; Technetium-99 Pertechnetate
  • 2) By Gallium-68: Gallium-68 DOTATATE; Gallium-68 PSMA
  • 3) By Iodine-131: Iodine-131 For Thyroid Cancer Treatment; Iodine-131 For Hyperthyroidism Treatment
  • 4) By Iodine-123: Iodine-123 For Thyroid Scans; Iodine-123 For Cardiac Imaging
  • 5) By Fludeoxyglucose-18F (FDG): FDG For Oncology Imaging; FDG For Brain Imaging
  • 6) By Yttrium-90: Yttrium-90 Microspheres For Liver Cancer; Yttrium-90 For Radioimmunotherapy
  • 7) By Lutetium (Lu) 177: Lutetium-177 PSMA For Prostate Cancer; Lutetium-177 DOTATATE For Neuroendocrine Tumors
  • 8) By Copper (Cu) 67: Copper-67 For Targeted Radiotherapy; Copper-67 In Clinical Trials
  • 9) By Copper (Cu) 64: Copper-64 For PET Imaging; Copper-64 For Radiotherapy
  • 10) By Other Radioisotopes: Radium-223; Samarium-153; Other Emerging Radioisotopes In Theranostics
  • Companies Mentioned: Lantheus Holdings Inc.; Cardinal Health Inc.; GE Healthcare Inc.; Bayer AG; Novartis AG; Siemens Healthineers; Orano Med; Curium SAS; IBA Molecular; The Eckert & Ziegler Group; Advanced Accelerator Applications (AAA); Telix Pharmaceuticals Limited.; Abdera Therapeutics; Blue Earth Diagnostics; Sirtex Medical Limited; Y-mAbs Therapeutics Inc.; ITM Radiopharma; NorthStar Medical Radioisotopes LLC; Trasis S.A.; Molecular Targeting Technologies Inc.; RadioMedix Inc; Clarity Pharmaceuticals; Actinium Pharmaceuticals Inc.; Navidea Biopharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiotheranostics Market Characteristics

3. Radiotheranostics Market Trends And Strategies

4. Radiotheranostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Radiotheranostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Radiotheranostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Radiotheranostics Market Growth Rate Analysis
  • 5.4. Global Radiotheranostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Radiotheranostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Radiotheranostics Total Addressable Market (TAM)

6. Radiotheranostics Market Segmentation

  • 6.1. Global Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Technetium-99
  • Gallium-68
  • Iodine-131
  • Iodine-123
  • Fludeoxyglucose-18F
  • Yttrium-90
  • Lutetium (Lu) 177
  • Copper (Cu) 67
  • Copper (Cu) 64
  • Other Radioisotopes
  • 6.2. Global Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Targeted Therapeutic
  • Targeted Diagnostic
  • 6.3. Global Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Non-Oncology
  • 6.4. Global Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Other End-Users
  • 6.5. Global Radiotheranostics Market, Sub-Segmentation Of Technetium-99, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Technetium-99m
  • Technetium-99 Pertechnetate
  • 6.6. Global Radiotheranostics Market, Sub-Segmentation Of Gallium-68, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gallium-68 DOTATATE
  • Gallium-68 PSMA
  • 6.7. Global Radiotheranostics Market, Sub-Segmentation Of Iodine-131, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Iodine-131 For Thyroid Cancer Treatment
  • Iodine-131 For Hyperthyroidism Treatment
  • 6.8. Global Radiotheranostics Market, Sub-Segmentation Of Iodine-123, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Iodine-123 For Thyroid Scans
  • Iodine-123 For Cardiac Imaging
  • 6.9. Global Radiotheranostics Market, Sub-Segmentation Of Fludeoxyglucose-18F (FDG), By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • FDG For Oncology Imaging
  • FDG For Brain Imaging
  • 6.10. Global Radiotheranostics Market, Sub-Segmentation Of Yttrium-90, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Yttrium-90 Microspheres For Liver Cancer
  • Yttrium-90 For Radioimmunotherapy
  • 6.11. Global Radiotheranostics Market, Sub-Segmentation Of Lutetium (Lu) 177, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lutetium-177 PSMA For Prostate Cancer
  • Lutetium-177 DOTATATE For Neuroendocrine Tumors
  • 6.12. Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 67, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Copper-67 For Targeted Radiotherapy
  • Copper-67 In Clinical Trials
  • 6.13. Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 64, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Copper-64 For PET Imaging
  • Copper-64 For Radiotherapy
  • 6.14. Global Radiotheranostics Market, Sub-Segmentation Of Other Radioisotopes, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radium-223; Samarium-153
  • Other Emerging Radioisotopes In Theranostics

7. Radiotheranostics Market Regional And Country Analysis

  • 7.1. Global Radiotheranostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Radiotheranostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Radiotheranostics Market

  • 8.1. Asia-Pacific Radiotheranostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Radiotheranostics Market

  • 9.1. China Radiotheranostics Market Overview
  • 9.2. China Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Radiotheranostics Market

  • 10.1. India Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Radiotheranostics Market

  • 11.1. Japan Radiotheranostics Market Overview
  • 11.2. Japan Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Radiotheranostics Market

  • 12.1. Australia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Radiotheranostics Market

  • 13.1. Indonesia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Radiotheranostics Market

  • 14.1. South Korea Radiotheranostics Market Overview
  • 14.2. South Korea Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Radiotheranostics Market

  • 15.1. Western Europe Radiotheranostics Market Overview
  • 15.2. Western Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Radiotheranostics Market

  • 16.1. UK Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Radiotheranostics Market

  • 17.1. Germany Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Radiotheranostics Market

  • 18.1. France Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Radiotheranostics Market

  • 19.1. Italy Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Radiotheranostics Market

  • 20.1. Spain Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Radiotheranostics Market

  • 21.1. Eastern Europe Radiotheranostics Market Overview
  • 21.2. Eastern Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Radiotheranostics Market

  • 22.1. Russia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Radiotheranostics Market

  • 23.1. North America Radiotheranostics Market Overview
  • 23.2. North America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Radiotheranostics Market

  • 24.1. USA Radiotheranostics Market Overview
  • 24.2. USA Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Radiotheranostics Market

  • 25.1. Canada Radiotheranostics Market Overview
  • 25.2. Canada Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Radiotheranostics Market

  • 26.1. South America Radiotheranostics Market Overview
  • 26.2. South America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Radiotheranostics Market

  • 27.1. Brazil Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Radiotheranostics Market

  • 28.1. Middle East Radiotheranostics Market Overview
  • 28.2. Middle East Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Radiotheranostics Market

  • 29.1. Africa Radiotheranostics Market Overview
  • 29.2. Africa Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Radiotheranostics Market Competitive Landscape And Company Profiles

  • 30.1. Radiotheranostics Market Competitive Landscape
  • 30.2. Radiotheranostics Market Company Profiles
    • 30.2.1. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GE Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Radiotheranostics Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers
  • 31.2. Orano Med
  • 31.3. Curium SAS
  • 31.4. IBA Molecular
  • 31.5. The Eckert & Ziegler Group
  • 31.6. Advanced Accelerator Applications (AAA)
  • 31.7. Telix Pharmaceuticals Limited.
  • 31.8. Abdera Therapeutics
  • 31.9. Blue Earth Diagnostics
  • 31.10. Sirtex Medical Limited
  • 31.11. Y-mAbs Therapeutics Inc.
  • 31.12. ITM Radiopharma
  • 31.13. NorthStar Medical Radioisotopes LLC
  • 31.14. Trasis S.A.
  • 31.15. Molecular Targeting Technologies Inc.

32. Global Radiotheranostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiotheranostics Market

34. Recent Developments In The Radiotheranostics Market

35. Radiotheranostics Market High Potential Countries, Segments and Strategies

  • 35.1 Radiotheranostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Radiotheranostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Radiotheranostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer